Specifically, IL-1β levels were significantly greater in AD patients carrying the IL-1β-31TT genotype than in those carrying the CT or the CC genotype and the healthy controls (Fig 1A); in addition, a significant difference was observed between the CT or the CC genotype and the healthy controls (Fig 1A). The gene discussed is IL1B; the disease is Alzheimer disease.